Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
ABBOTT VASCULAR INTERNATIONAL from Machelen (Brab.), company number BE0886537933, closed financial year 2025 with a result of € 337,289 after tax. For that financial year ABBOTT VASCULAR INTERNATIONAL recorded revenue of € 54.4 million and equity of € 21.5 million. Compared with financial year 2024, the result moved from € 750,074 to € 337,289. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 21.5 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 337,289
▼ 55% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 21.5 million.
People and assets in 2025
102.7
▲ 8.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 21.6 million
▼ 17% vs 2024
€ 210,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 22.2 million
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 251 days on average.
€ 9.6 million
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 47,737,704 | € 50,298,255 | € 54,908,674 | € 54,424,732 | ▼ 1% |
| Profit after taxes | € 2,456,047 | € 1,448,977 | € 750,074 | € 337,289 | ▼ 55% |
| Equity | € 18,989,573 | € 20,438,550 | € 21,188,623 | € 21,525,908 | ▲ 2% |
| Total debts | € 24,498,167 | € 27,257,506 | € 33,769,849 | € 31,830,943 | ▼ 6% |
| Retained profit | € 18,971,023 | € 20,420,000 | € 21,170,073 | € 21,507,358 | ▲ 2% |
| Balance sheet total | € 44,138,591 | € 48,346,907 | € 55,609,323 | € 54,007,702 | ▼ 3% |
| Employees (FTE) | 96.5 | 95.6 | 94.1 | 102.7 | ▲ 8.6 |
By revenue, ABBOTT VASCULAR INTERNATIONAL ranks 19th of 25 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Machelen (Brab.) that publish figures (fiscal year 2025).
Key figures of ABBOTT VASCULAR INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about ABBOTT VASCULAR INTERNATIONAL the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to ABBOTT VASCULAR INTERNATIONAL?
What happened at ABBOTT VASCULAR INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bradley Jay Slater stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 337,289 (▼ 55% vs 2024). Source: NBB ↗
- Maya Wakim became a director. NBB
- Bradley Jay Slater became a director. NBB
- Samih Al Mawass became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Incorporation, published in the Gazette. Source: Staatsblad ↗
In short
From € 2.5 million profit in 2022 to € 337,289 profit in 2025.
Paid € 3.5 million in corporate taxes since 2022.
Best year ever: 2022, with € 2.5 million profit.
Management
Behind ABBOTT VASCULAR INTERNATIONAL are Maya Wakim and Samih Al Mawass.
Directors
According to the 2025 annual accounts
Maya Wakim
Director
since 2026
Samih Al Mawass
Director
since 2021
Bradley Jay Slater
Director
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Culliganlaan 2B
1831 Machelen (Brab.)
Culliganlaan 2 box B
1831 Machelen (Brab.)
Active since 1 February 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Machelen (Brab.)
Same main activity (Groothandel in farmaceutische en medische artikelen), 33 active companies in Machelen (Brab.), largest first.
€ 3.6 billion revenue · 2025
€ 378.6 million revenue · 2025
€ 330 million revenue · 2025
€ 296.7 million revenue · 2025
€ 195.9 million revenue · 2025
€ 175.2 million revenue · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- ABBOTT LABORATORIES VASCULAR ENTERPRISES LIMITED(oprichter) 100%
Details
- Company number
- 0886.537.933
- VAT number
- BE 0886.537.933
- Registered office
- Culliganlaan 2B, 1831 Machelen (Brab.)
- Names & denominations
- ABBOTT VASCULAR INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2007
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van hoofdkantoren